Lab & Pathology Information Systems · Healthcare & Life Sciences
Should you build or buy Anatomic Pathology Case Management?
Anatomic pathology case management software handles the full lifecycle of pathology specimens — from accessioning and grossing through staining, slide preparation, sign-out, and synoptic reporting. It encodes laboratory-specific workflows and CAP-accredited cancer reporting templates that pathologists use to produce diagnostic reports meeting accreditation standards.
The build-vs-buy decision for Anatomic Pathology Case Management turns on how much of your institution's competitive future depends on owning the data schema for AI diagnostic integration versus how much operational value you capture from vendor-maintained CAP synoptic templates and existing instrument connectors; the specifics — whether you're building AI pathology capabilities or running accredited clinical service — decide it.
Build it, buy it, or bridge?
When building makes sense
Building anatomic pathology case management infrastructure makes sense when an institution's computational pathology program is real, funded, and strategically central — not theoretical. For academic cancer centers where AI diagnostic overlays, training data curation, and case routing to ML models are active priorities, owning the case data schema is genuine infrastructure, not just a philosophical preference. The build case also gets stronger as institutions develop proprietary staining panels, grossing protocols, or subspecialty routing logic that vendor defaults don't accommodate cleanly. If your pathology AI roadmap requires controlling which cases flow to which models, how those results integrate into the sign-out workflow, and how training data is labeled and versioned, building that layer on top of a well-defined data architecture makes competitive sense. The prerequisite is that the AI ambitions are actually funded and staffed — the build case falls apart quickly when it's a future aspiration rather than an active program.
When buying makes sense
Buying earns its keep when a lab's core requirement is running CAP-accredited anatomic pathology service with current synoptic cancer reporting templates. The College of American Pathologists updates its cancer protocol checklists annually, and vendors like Clinisys (PowerPath) and NovoPath incorporate those changes as part of the contract. Maintaining that compliance independently requires dedicated pathology informatics staff who track CAP updates, validate template changes, and manage the implementation. That's a real operational burden most institutions are better served outsourcing. Beyond CAP compliance, the integration surface for anatomic pathology is substantial: grossing stations, staining equipment, slide scanners, EHR systems, and digital pathology platforms all require connectors that vendor platforms have built over years of direct hardware partnerships. A lab running accredited service for clinical care — without a specific AI program requiring data architecture control — captures most of its value from vendor selection and configuration rather than custom development.
The desk read
Buying earns its keep when your lab is running CAP-accredited synoptic reporting, because the templates for cancer protocols get updated annually by the College of American Pathologists and keeping pace manually is a real operational burden. Vendors like Clinisys (PowerPath) and NovoPath carry those updates as part of the contract, and their instrument interfaces for grossing stations and staining panels already exist. The integration surface with your digital pathology and EHR systems is also substantial enough that a vendor's existing connectors matter.
The build case gets more serious as AI diagnostic overlays become central to pathology practice. If your institution has a research program around computational pathology, owning the case data schema and the workflow that routes cases to AI models starts to look like strategic infrastructure rather than a commodity system. The question is whether your data architecture ambitions are real and funded, or theoretical.
Frequently asked
What is Anatomic Pathology Case Management?
Anatomic pathology case management software handles the full lifecycle of pathology specimens — from accessioning and grossing through staining, slide preparation, sign-out, and synoptic reporting. It encodes laboratory-specific workflows and CAP-accredited cancer reporting templates that pathologists use to produce diagnostic reports meeting accreditation standards.
When does building Anatomic Pathology Case Management make sense?
Building makes sense when an institution has a real, funded computational pathology program and needs to own the case data schema to control AI model routing and training data curation — not as a future aspiration but as an active strategic priority.
When does buying Anatomic Pathology Case Management make sense?
Buying is the right call for labs running CAP-accredited clinical service, where vendor-maintained synoptic cancer reporting templates and existing integrations for grossing stations, scanners, and EHR systems eliminate the operational burden of maintaining those capabilities independently.
What are the main Anatomic Pathology Case Management vendors?
Representative vendors include NovoPath, CGM AP Easy, XIFIN (formerly LigoLab AP), Clinisys (PowerPath). B4 Pro scores the full set.
What are CAP synoptic reporting templates and why do they matter?
The College of American Pathologists publishes cancer reporting protocols specifying required data elements for pathology reports across tumor types. Accredited labs must use current versions of these templates. Vendors incorporate annual CAP updates automatically, while self-built systems require in-house pathology informatics staff to track and implement each revision.